Changes in CD4+ T-cells and HIV RNA resulting from combination of anti-TB therapy with Dzherelo in TB/HIV dually infected patients

The open-label, phase II clinical trial of antituberculosis therapy (ATT) with or without oral immunomodulator Dzherelo (Immunoxel) was conducted in TB/HIV coinfected, antiretroviral therapy naïve patients to evaluate the effect on CD4 T-lymphocyte counts and viral load. The arm A (n = 20) received...

Descripción completa

Detalles Bibliográficos
Autores principales: Nikolaeva, Lyudmila G, Maystat, Tatyana V, Masyuk, Lilia A, Pylypchuk, Volodymyr S, Volyanskii, Yuri L, Kutsyna, Galyna A
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2009
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2761183/
https://www.ncbi.nlm.nih.gov/pubmed/19920896

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2761183/
https://www.ncbi.nlm.nih.gov/pubmed/19920896

Ejemplares similares